MedDataX Logo

Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014

NCT ID: NCT01503034

Last Updated: 2018-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

394 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-14

Study Completion Date

2015-09-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a non-interventional, retrospective, multicentre study involving women having had a breast cancer during their pregnancy, diagnosed between 2000 and 2014 (cases) and non-pregnant women having had a breast cancer between 2000 and 2009 (controls).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Breast Cancer During Pregnancy

NCT02102282

Pregnancy Breast Cancer
UNKNOWN

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

NCT03673306

Breast Cancer
COMPLETED

Registry Study of Pregnancy and Breast Cancer

NCT04603820

Breast Cancer and Pregnancy
ACTIVE_NOT_RECRUITING

Reproductive Health in Breast Cancer Survivor

NCT06756802

Breast Cancer
ACTIVE_NOT_RECRUITING

Pregnant Exposure to Persistent Organic Pollutants

NCT03419026

Breast Cancer
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators will explain the purpose of the study to the eligible patients, still alive, and will inform them verbally and in writing, using the information note, of their possibility of refusal. No information will be made for deceased patients.

The investigators will complete the case report forms on paper and then will send them by mail.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study cohort

This cohort is made up of pregnant women with a breast cancer diagnosed between 2000 and 2014.

No interventions assigned to this group

Compared cohort

This cohort is made up of non-pregnant women with a breast cancer diagnosed between 2000 and 2009.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women aged 18 or over
* Confirmed histological diagnosis of invasive breast cancer
* No known metastasis
* For the cases :

* Patients pregnant at the time of the first diagnosis
* 1st diagnosis between 2000 and 2014
* For the controls :

* Patients not pregnant at the time of the first diagnosis
* 1st diagnosis between 2000 and 2009

Exclusion Criteria

* Patients who have undergone an induced abortion after the diagnosis of breast cancer
* Patients with a history of breast cancer
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Oscar Lambret

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laurence VANLEMMENS, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Oscar Lambret

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Sainte Catherine

Avignon, , France

Site Status

Cabinet Dr Le Guen Naas

Baud, , France

Site Status

Centre Hospitalier Universitaire

Besançon, , France

Site Status

Institut Bergonié

Bordeaux, , France

Site Status

CHR

Brest, , France

Site Status

Centre François Baclesse

Caen, , France

Site Status

Centre Hospitalier René Dubos

Cergy-Pontoise, , France

Site Status

Centre Jean Perrin

Clermont-Ferrand, , France

Site Status

Centre Léonard de Vinci

Dechy, , France

Site Status

Centre Georges François Leclerc

Dijon, , France

Site Status

Centre Hospitalier Départemental de Vendée

La Roche-sur-Yon, , France

Site Status

Centre Oscar Lambret

Lille, , France

Site Status

Centre de Pharmacovigilance

Lille, , France

Site Status

Centre Hospitalier de Bretagne Sud

Lorient, , France

Site Status

Centre Léon Bérard

Lyon, , France

Site Status

Institut Paoli Calmettes

Marseille, , France

Site Status

CHRU La Peyronie et Centre Val d'Aurelle

Montpellier, , France

Site Status

Centre Catherine de Sienne

Nantes, , France

Site Status

Centre Antoine Lacassagne

Nice, , France

Site Status

Institut Curie

Paris, , France

Site Status

Hôpital Saint-Louis

Paris, , France

Site Status

Hôpital Cochin

Paris, , France

Site Status

Hôpital Tenon

Paris, , France

Site Status

Centre Hospitalier Lyon-Sud

Pierre-Bénite, , France

Site Status

Institut Jean Godinot

Reims, , France

Site Status

Polyclinique de Courlancy

Reims, , France

Site Status

Centre Eugene Marquis

Rennes, , France

Site Status

Centre Henri Becquerel

Rouen, , France

Site Status

Clinique Radiologique

Saint-Brieuc, , France

Site Status

Centre René Huguenin

Saint-Cloud, , France

Site Status

Centre René Gauducheau

Saint-Herblain, , France

Site Status

Centre Paul Strauss

Strasbourg, , France

Site Status

Institut Claudius Régaud

Toulouse, , France

Site Status

Cabinet Dr Leroy

Tourcoing, , France

Site Status

Hôpital Bretonneau - Centre régional de cancérologie Henry Kaplan

Tours, , France

Site Status

Centre Alexis Vautrin

Vandœuvre-lès-Nancy, , France

Site Status

Institut Gustave Roussy

Villejuif, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cancer et grossesse

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breast Cancer in Pregnancy Register Study
NCT00196833 RECRUITING
Optimizing the Care Pathways of Patients Treated for Operable Breast.
NCT02813317 COMPLETED
Outcome of Pregnancy and Breast Cancer
NCT02774915 UNKNOWN
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT02997384 UNKNOWN
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ACTIVE_NOT_RECRUITING NA
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 COMPLETED NA
Angiogenesis in Early Breast Cancer for Prognosis Prediction
NCT00599105 COMPLETED NA
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749 NOT_YET_RECRUITING
IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)
NCT04012229 COMPLETED
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 RECRUITING
Management of Women With BRCA1/2 Mutation
NCT03211611 COMPLETED
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
NCT00293865 COMPLETED NA
Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT01459003 COMPLETED PHASE3
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750 COMPLETED
Breast Cancer and Chemo-amennorhea
NCT01867229 COMPLETED
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 RECRUITING NA
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 COMPLETED
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse
NCT03630653 TERMINATED NA
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 UNKNOWN
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 RECRUITING
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
NCT02850302 COMPLETED NA
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ACTIVE_NOT_RECRUITING
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
NCT05981326 RECRUITING NA
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 COMPLETED
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 UNKNOWN